Methylphenidate for fatigue in ambulatory men with prostate cancer (Q39993765)

16 September 2017

Methylphenidate for fatigue in ambulatory men with prostate cancer (English)

1 reference

16 September 2017

1 reference

6

1 reference

16 September 2017

4

Howard Scher

1 reference

16 September 2017

5

Susan Slovin

1 reference

16 September 2017

Andrew J Roth

1

1 reference

16 September 2017

Christian Nelson

2

1 reference

16 September 2017

Barry Rosenfeld

3

1 reference

16 September 2017

Noelle O'Shea

7

1 reference

16 September 2017

Gabrielle Arauz

8

1 reference

16 September 2017

William Breitbart

9

1 reference

16 September 2017

language of work or name

English

0 references

publication date

1 November 2010

1 reference

16 September 2017

1 reference

16 September 2017

116

1 reference

16 September 2017

21

1 reference

16 September 2017

5102-5110

1 reference

A pilot study evaluating the safety and efficacy of modafinal for cancer-related fatigue

16 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3632439

Fatigue is the most important symptom for advanced cancer patients who have had chemotherapy

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3632439

Use of methylphenidate in patients with cancer

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3632439

Controlled physical activity trials in cancer survivors: a systematic review and meta-analysis.

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3632439

Systematic review of barriers to the recruitment of older patients with cancer onto clinical trials

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3632439

Evidence-based treatment for cancer-related fatigue

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3632439

Fatigue and cancer: causes, prevalence and treatment approaches

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3632439

What you see may not be what you get: a brief, nontechnical introduction to overfitting in regression-type models

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3632439

Fatigue in cancer patients receiving chemotherapy: an analysis of published studies

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3632439

Assessment and management of cancer-related fatigue in adults

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3632439

Modern statistical methods for handling missing repeated measurements in obesity trial data: beyond LOCF.

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3632439

Assessing Response Profiles from Incomplete Longitudinal Clinical Trial Data Under Regulatory Considerations

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3632439

Fatigue in patients with advanced cancer: a review

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3632439

NCCN Practice Guidelines for Cancer-Related Fatigue

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3632439

A randomized, double-blind, placebo-controlled trial of psychostimulants for the treatment of fatigue in ambulatory patients with human immunodeficiency virus disease

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3632439

Results of a phase II study using estramustine phosphate and vinblastine in combination with high-dose three-dimensional conformal radiotherapy for patients with locally advanced prostate cancer

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3632439

Biopsychosocial aspects of prostate cancer.

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3632439

The treatment of advanced prostate cancer with ketoconazole: safety issues

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3632439

The Functional Assessment of Cancer Therapy scale: development and validation of the general measure

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3632439

Quality of life of patients with prostate cancer and their spouses. The value of a data base in clinical care

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3632439

The hospital anxiety and depression scale

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3632439

General versus systematic inquiry about emergent clinical events with SAFTEE: implications for clinical research

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3632439

Psychiatry: cognitive therapy for depression and panic disorder

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3632439

Bupropion sustained release treatment reduces fatigue in cancer patients

15 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3632439

Response of HIV-Related Depression to Psychostimulants: Case Reports

15 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3632439

Use of methylphenidate as an adjuvant to narcotic analgesics in patients with advanced cancer

15 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3632439

Psychostimulant response in AIDS-related complex patients.

15 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3632439

Pemoline. An alternative psychostimulant for the management of depressive disorders in cancer patients

15 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3632439

Efficacy of dexmethylphenidate for the treatment of fatigue after cancer chemotherapy: a randomized clinical trial

15 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3632439

Randomized controlled trial of resistance or aerobic exercise in men receiving radiation therapy for prostate cancer

20 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3632439

Clinically important improvement in the intensity of fatigue in patients with advanced cancer.

20 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3632439

Impact of androgen deprivation therapy on physical and cognitive function, as well as quality of life of patients with nonmetastatic prostate cancer.

20 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3632439

Epidemiology of cancer-related fatigue in the Swedish twin registry.

20 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3632439

A randomized, controlled trial of aerobic exercise for treatment-related fatigue in men receiving radical external beam radiotherapy for localized prostate carcinoma.

20 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3632439

Resistance Exercise in Men Receiving Androgen Deprivation Therapy for Prostate Cancer

20 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3632439

Methylphenidate for fatigue in advanced cancer: a prospective open-label pilot study

20 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3632439

A study to investigate the prevalence, severity and correlates of fatigue among patients with cancer in comparison with a control group of volunteers without cancer.

20 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3632439

Fatigue in patients with prostate cancer receiving hormone therapy.

20 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3632439

Prospective study of fatigue in localized prostate cancer patients undergoing radiotherapy.

20 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3632439

The Memorial Symptom Assessment Scale: an instrument for the evaluation of symptom prevalence, characteristics and distress.

20 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3632439

Donepezil for cancer fatigue: a double-blind, randomized, placebo-controlled trial

20 August 2018

1 reference

12 December 2020

Use of psychostimulants in medically ill depressed patients

1 reference

12 December 2020

Patient-controlled methylphenidate for cancer fatigue: a double-blind, randomized, placebo-controlled trial

1 reference

12 December 2020

Response to low-dose ketoconazole and subsequent dose escalation to high-dose ketoconazole in patients with androgen-independent prostate cancer

1 reference

12 December 2020

Treatment of depression in the medically ill elderly with methylphenidate

1 reference

12 December 2020

The rapid assessment of fatigue severity in cancer patients: use of the Brief Fatigue Inventory

1 reference

12 December 2020

Methylphenidate associated with narcotics for the treatment of cancer pain

1 reference

12 December 2020

Benefits of a physical activity intervention for men with prostate cancer

1 reference

12 December 2020

Exercise prevents fatigue and improves quality of life in prostate cancer patients undergoing radiotherapy

1 reference

12 December 2020

Asthenia in patients with advanced cancer. Issues in symptom control. Part 1

1 reference

12 December 2020

Fatigue in cancer patients

1 reference

12 December 2020

On the practice of dichotomization of quantitative variables

1 reference

12 December 2020

The fatigue severity scale. Application to patients with multiple sclerosis and systemic lupus erythematosus

1 reference

12 December 2020

Dichotomizing continuous predictors in multiple regression: a bad idea

1 reference

12 December 2020

Methods to explain the clinical significance of health status measures

1 reference

Crossref

https://api.crossref.org/works/10.1002%2FCNCR.25424

7 January 2021

inferred from DOI database lookup

Identifiers

DOI

10.1002/CNCR.25424

1 reference

release_nljr4vumxrezhonhzn5v5twf2a

16 September 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/nljr4vumxrezhonhzn5v5twf2a

24 November 2022

mapped directly with Wikidata item

1 reference

16 September 2017

PubMed publication ID

20665492

1 reference